Overview

Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients

Status:
Unknown status

Trial end date:
2010-06-01

Target enrollment:

Participant gender:

Summary

The use of N-acetylcysteine and ascorbic acid reduce the incidence of radiographic contrast agent induced reduction in renal function in Intensive Care Unit patients.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Thessaly

Treatments:

Acetylcysteine
Ascorbic Acid
N-monoacetylcystine